The history of bancroftian lymphatic filariasis in Australasia and Oceania: Is there a threat of re-occurrence in mainland Australia?

27Citations
Citations of this article
113Readers
Mendeley users who have this article in their library.

Abstract

Lymphatic filariasis (LF) infects an estimated 120 million people worldwide, with a further 856 million considered at risk of infection and requiring preventative chemotherapy. The majority of LF infections are caused by Wuchereria bancrofti, named in honour of the Australian physician Joseph Bancroft, with the remainder due to Brugia malayi and B. timori. Infection with LF through the bite of an infected mosquito, can lead to the development of the condition known as elephantiasis, where swelling due to oedema leads to loss of function in the affected area and thickening of the skin, ‘like an elephant'. LF has previously been endemic in Australia, although currently, no autochthonous cases occur there. Human immigration to Australia from LF-endemic countries, including those close to Australia, and the presence of susceptible mosquitoes that can act as suitable vectors, heighten the possibility of the reintroduction of LF into this country. In this review, we examine the history of LF in Australia and Oceania and weigh up the potential risk of its re-occurrence on mainland Australia.

Cite

CITATION STYLE

APA

Gordon, C. A., Jones, M. K., & McManus, D. P. (2018, June 4). The history of bancroftian lymphatic filariasis in Australasia and Oceania: Is there a threat of re-occurrence in mainland Australia? Tropical Medicine and Infectious Disease. MDPI AG. https://doi.org/10.3390/tropicalmed3020058

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free